Cognizant services will provide automation and digital technologies that can reduce cost of service and speed time to market
TEANECK, N.J., March 25, 2024 /PRNewswire/ -- Cognizant (NASDAQ:CTSH) announced today it has been selected by Clario, a healthcare research technology company that delivers leading endpoint technology solutions for clinical trials, to support its global IT infrastructure and applications. The collaboration will help Clario advance its employee and customer offerings in support of its mission to transform lives by generating high-quality evidence for more informed decision making.